Ketek: More safety warnings will affect sales
The antibiotic Ketek is likely to face more safety warnings. Sanofi-Aventis’ stock for the sales of Ketek will most likely be hurt in the United States and Europe. (New Ratings)
« FDA seeks outside review of Ketek antibiotic on December 14 and 15 | Main | Ketek Drug Maker Continues Discussion with FDA »